Schonfeld Strategic Advisors LLC - VIRIDIAN THERAPEUTICS INC ownership

VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 139 filers reported holding VIRIDIAN THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.5%.

Quarter-by-quarter ownership
Schonfeld Strategic Advisors LLC ownership history of VIRIDIAN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,657,287
+198.1%
108,037
+362.3%
0.01%
+160.0%
Q2 2023$555,900
-39.4%
23,367
-25.6%
0.01%
-37.5%
Q4 2022$917,194
-2.9%
31,400
-40.3%
0.01%0.0%
Q3 2022$945,000
+122.4%
52,623
+144.6%
0.01%
+100.0%
Q4 2021$425,000
-41.3%
21,512
-51.1%
0.00%
-42.9%
Q3 2021$724,00044,0000.01%
Other shareholders
VIRIDIAN THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 944,092$15,530,0005.65%
Ally Bridge Group (NY) LLC 904,978$14,887,0004.38%
COMMODORE CAPITAL LP 667,674$10,983,0002.90%
FRAZIER MANAGEMENT LLC 1,505,200$24,761,0001.98%
Logos Global Management LP 1,500,000$24,675,0001.78%
Ghost Tree Capital, LLC 350,000$5,758,0001.68%
SILVERARC CAPITAL MANAGEMENT, LLC 106,078$1,745,0000.99%
Vivo Capital, LLC 1,300,000$21,385,0000.96%
ACUTA CAPITAL PARTNERS, LLC 135,807$2,234,0000.79%
BVF INC/IL 804,126$13,228,0000.52%
View complete list of VIRIDIAN THERAPEUTICS INC shareholders